Material Type

• Blood (whole) (1)
• Buffy coat (1)
• Isolated peripheral blood mononuclear cells (non viable) (2)
• Other (4)
• Plasma (double spun) (1)
• Plasma (single spun) (3)
• Red Blood Cells (1)
• Serum (3)
• Stool (2)
• Urine (first morning) (1)
• Urine (random) (4)

Microscopic Assessment

• Affected (2)
• Not applicable (4)

Storage Temperature

• RT (2)
• -85°C to -60°C (5)

Preservation Type

• N/A (1)

Associated Data

• Clinical records (4)
• Followup records (5)
• Freezer temperature logs (5)
• Microbiological results (2)
• Participant Ethnicity (3)
• Physiological/biochemical measurements (2)
• Survey data (2)
• Treatment records (5)

Timeframe

• Immediate (3)
• 0 - 3 months (5)
• 3 - 6 months (4)
• > 6 months (1)

Participant Count

• 1 - 10 (1)
• 11 - 100 (2)
• 101 - 500 (5)

Sex

• Both sexes (5)

Age Range

• Young child (2 - 6 years) (1)
• Child (6 - 12 years) (2)
• Adolescent (12 - 18 years) (2)
• Young adult (18 - 40 years) (4)
• Adult (> 40 years) (3)

Biobank Services

• Ability to recontact (2)
• Cell culture (2)
• Digital imaging (1)
• Infectious strain isolation (1)
• Molecular Extractions (2)
• Nucleic acid extraction (3)

Collection Type

• Clinical Trial (2)
• Cohort (1)
• Cross-sectional (2)

Consent Restriction

• No Commercial restriction (3)
• No Disease area restriction (3)
• No Export restriction (5)
• No Genetic analysis restriction (5)
• No Human genetic analysis restriction (4)
• No restrictions (1)
• No Project specific restriction (5)
• No Scope of use restriction (3)

Collection Status

• Completed (2)
• In progress (4)
• Not-started (1)

Access Condition

• Open only through collaboration (5)

Country

• Democratic Republic of the Congo (2)
• Peru (2)
• Spain (1)
• United States (1)

County